Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biodegradable Stents in Primary Sclerosing Cholangitis
Sponsor: King's College Hospital NHS Trust
Summary
In patients with PSC, endoscopic therapy of strictures aims to improve cholestasis by relieving the biliary obstruction via endoscopic biliary dilatation with consideration of plastic stents in strictures refractory to dilatation due to the risk of pancreatitis and cholangitis . Short term stents have been shown to have similar recurrence-free rates compared to dilatation in a randomised control trial; however, this was terminated after interim analysis due to higher rates of serious adverse events in the stent group. The long term benefits are unclear; however, it may lead to improved survival compared to predicted survival. In this group of patients with limited treatment options, biodegradable stents may provide an attractive additional treatment modality in the management of high grade strictures.
Official title: Pilot Study of Biodegradable STents in Primary Sclerosing Cholangitis - BSTPSC
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-03-01
Completion Date
2027-04-01
Last Updated
2026-05-29
Healthy Volunteers
No
Conditions
Interventions
archimedes stent
archimedes stent for HGS
Locations (1)
King's College Hospital, London
London, United Kingdom